Thomas P Bleck

  • 8166 Citations
1983 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

neurocritical care, status epilepticus, subarachnoid hemorrhage, neurogenic respiratory failure, intracerebral hemorrhage, Guillain-Barre syndrome, central nervous system infections, clostridial diseases, bioterrorism

Thomas P Bleck MD MCCM is professor of neurology at the Northwestern University Feinberg School of Medicine. In 2018 he retired as professor emeritus of neurological sciences, neurosurgery, internal medicine, and anesthesiology at Rush Medical College, where he was a neurointensivist and the director of clinical neurophysiology. From 2009 – 2015, he was the associate chief medical officer for critical care. He was the founding president of the Neurocritical Care Society. From 1992 – 2015 he was the neuroscience section editor of Critical Care Medicine, and is currently an associate editor. He also serves on the editorial boards of Annals of Intensive Care, and Epilepsy Currents. For 12 years, he was a member of the Council of the Society of Critical Care Medicine. In 2015, the American College of Critical Care Medicine and the SCCM elected him a Master of Critical Care Medicine; there are 82 masters out of nearly 18,000 members. He previously served on the board of the American Board of Clinical Neurophysiology, the writing committee of the American Board of Psychiatry and Neurology, and the American Board of Internal Medicine subspecialty exam committee in critical care medicine. In 2018, he was appointed to the ABPN neurocritical care examination development committee. He is an elected fellow of 11 professional societies. In 2017, he was elected to the board of directors of the American Neurological Association. In 2018, he received the SCCM lifetime achievement award. From 1990 – 2006, he directed the neuroscience intensive care unit at the University of Virginia as the Louise Nerancy eminent scholar in neurology. From 2006 – 2009, he chaired the neurology department of Evanston Northwestern Healthcare, and was professor and vice-chair for academic programs at Northwestern, where he also directed the section of neurocritical care. In 2009, he moved to Rush as the associate chief medical officer for critical care. In 2017, he was the interim neurology residency program director. His research interests include subarachnoid hemorrhage, intracerebral hemorrhage, head injury, status epilepticus, infections, neuromuscular respiratory failure, and the ICU management of the organ donor. He has published 194 papers, 131 abstracts, 21 editorials, and 197 books and book chapters; and conducted more than 560 national and international visiting appointments and lectureships in 30 countries. Dr. Bleck is board certified in internal medicine, with subspecialty certification in critical care medicine; neurology, with subspecialty certifications in vascular neurology, epilepsy, and neurocritical care; clinical neurophysiology; and in neurocritical care by both the United Council on Neurological Subspecialties and the Committee on Advanced Surgical Training of the Society of Neurological Surgeons.

Certifications and Licenses

Neurocritical Care
Epilepsy
Vascular Neurology
Neurology
Critical Care Medicine
Internal Medicine

Training Experience

1980Residency, Rush Presbyterian Saint Luke's Medical Center
1982Residency, Rush Presbyterian Saint Luke's Medical Center
1983Fellowship, Rush Presbyterian Saint Luke's Medical Center

Education/Academic qualification

MD, Rush Medical Collage

… → 1977

Research interests

  • Critical Care
  • Epidemiology
  • Infectious Diseases
  • Nervous System Diseases

Fingerprint Dive into the research topics where Thomas P Bleck is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 22 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial

Neurological Emergencies Treatment Trials, Apr 11 2020, In : The Lancet. 395, 10231, p. 1217-1224 8 p.

Research output: Contribution to journalArticle

Open Access
  • 2 Scopus citations

    Global Survey of Outcomes of Neurocritical Care Patients: Analysis of the PRINCE Study Part 2

    PRINCE Study Investigators, Feb 1 2020, In : Neurocritical Care. 32, 1, p. 88-103 16 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage

    Carlson, A. P., Hänggi, D., Wong, G. K., Etminan, N., Mayer, S. A., Aldrich, F., Diringer, M. N., Schmutzhard, E., Faleck, H. J., Ng, D., Saville, B. R., Bleck, T., Grubb, R., Miller, M., Suarez, J. I., Proskin, H. M., MacDonald, R. L., Abou-Hamden, A., Allan, R., Altaweel, L. & 69 others, Amar, A., Amin-Hanjani, S., Aziz, K., Bambakidis, N., Bojanowski, M., Bradac, O., Chou, S., Clark, W. M., Darsaut, T., Ebersole, K. C., Elijovich, L., Freeman, W. D., Goldbrunner, R., Graffagnino, C., Gupta, G., Habalova, J., Hadani, M., Harnof, S., Harrigan, M. R., Hatton, K., Helbok, R., Hrbac, T., Huttner, H. B., Jabbour, P., Jahromi, B., James, R., Jordan, J. D., Kelly, M., Kivisaari, R. P., Ko, N., Konczalla, J., Kung, D., Lahiri, S., Langer, D., Lawson, M., Lay, C., Ledoux, D., Lopez, G. A., Lui, W. M., Matouk, C., Mee, E. W., Meixensberger, J., Müller, O., Ng Yew Poh, V., Öhman, J., Papadakos, P., Patel, A. B., Polifka, A., Poon, W. S., Powers, C., Reavey-Cantwell, J., Redekop, G., Regelsberger, J., Rosenthal, G., Ryang, Y. M., Sauvageau, E., Seppelt, I., Smrcka, M., Spears, J., Thomas, A., Turner, R., Unterberg, A., Vajkoczy, P., Vespa, P., Walzman, D. E., Westermaier, T., Wong, J., Zaaroor, M. & Zabramski, J., Apr 1 2020, In : Stroke. p. 1142-1149 8 p.

    Research output: Contribution to journalArticle

  • The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus

    Sathe, A. G., Elm, J. J., Cloyd, J. C., Chamberlain, J. M., Silbergleit, R., Kapur, J., Cock, H. R., Fountain, N. B., Shinnar, S., Lowenstein, D. H., Conwit, R. A., Bleck, T. P. & Coles, L. D., Jun 1 2020, In : Epilepsia. 61, 6, p. e66-e70

    Research output: Contribution to journalArticle

  • The authors reply

    Cho, S. M., Farrokh, S., Whitman, G., Bleck, T. P. & Geocadin, R., Mar 1 2020, In : Critical care medicine. 48, 3, p. e267

    Research output: Contribution to journalArticle